Mr Peter S Hopewood, MD | |
210 Jones Rd, Suite 25, Falmouth, MA 02540 | |
(508) 540-9771 | |
(508) 540-3158 |
Full Name | Mr Peter S Hopewood |
---|---|
Gender | Male |
Speciality | General Surgery |
Experience | 48 Years |
Location | 210 Jones Rd, Falmouth, Massachusetts |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1275607525 | NPI | - | NPPES |
0150924 | Medicaid | MA | |
1700019 | Other | UNITED HEALTH CARE | |
29249 | Other | MA | HPHC |
720952 | Other | TUFTS | |
B48181 | Other | MA | BCBS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 44062 (Massachusetts) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Vna Of Cape Cod | Hyannis, MA | Home health agency |
Falmouth Hospital | Falmouth, MA | Hospital |
Cape Cod Healthcare | Hyannis, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Cape Cod Surgeons Pc | 7719020478 | 4 |
News Archive
The University of Alabama at Birmingham is the only university to be awarded grants in all three perinatal networks from the Eunice Kennedy Shriver National Institute of Child Health and Human Development to improve maternal and infant health.
Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that new data comparing BRCA1 and BRCA2 variant classifications between Myriad Genetics and a commonly used public genetic database was published in the journal The Oncologist.
N30 Pharmaceuticals, Inc., a clinical stage, biopharmaceutical company focused on the development of therapies for cystic fibrosis, announced today the presentation of key preclinical data for its novel inhibitors of S-nitrosoglutathione reductase.
Liquid biopsy can help to identify breast cancer patients with a poor prognosis earlier and more accurately than before, a new study from the University of Eastern Finland and Kuopio University Hospital shows.
› Verified 8 days ago
Entity Name | Cape Cod Surgeons Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366508194 PECOS PAC ID: 7719020478 Enrollment ID: O20100205000511 |
News Archive
The University of Alabama at Birmingham is the only university to be awarded grants in all three perinatal networks from the Eunice Kennedy Shriver National Institute of Child Health and Human Development to improve maternal and infant health.
Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that new data comparing BRCA1 and BRCA2 variant classifications between Myriad Genetics and a commonly used public genetic database was published in the journal The Oncologist.
N30 Pharmaceuticals, Inc., a clinical stage, biopharmaceutical company focused on the development of therapies for cystic fibrosis, announced today the presentation of key preclinical data for its novel inhibitors of S-nitrosoglutathione reductase.
Liquid biopsy can help to identify breast cancer patients with a poor prognosis earlier and more accurately than before, a new study from the University of Eastern Finland and Kuopio University Hospital shows.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Peter S Hopewood, MD 210 Jones Road, Suite 25, Falmouth, MA 02540 Ph: (508) 540-9771 | Mr Peter S Hopewood, MD 210 Jones Rd, Suite 25, Falmouth, MA 02540 Ph: (508) 540-9771 |
News Archive
The University of Alabama at Birmingham is the only university to be awarded grants in all three perinatal networks from the Eunice Kennedy Shriver National Institute of Child Health and Human Development to improve maternal and infant health.
Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that new data comparing BRCA1 and BRCA2 variant classifications between Myriad Genetics and a commonly used public genetic database was published in the journal The Oncologist.
N30 Pharmaceuticals, Inc., a clinical stage, biopharmaceutical company focused on the development of therapies for cystic fibrosis, announced today the presentation of key preclinical data for its novel inhibitors of S-nitrosoglutathione reductase.
Liquid biopsy can help to identify breast cancer patients with a poor prognosis earlier and more accurately than before, a new study from the University of Eastern Finland and Kuopio University Hospital shows.
› Verified 8 days ago
Mr. Patrick J Flynn, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 210 Jones Rd, Suite 25, Falmouth, MA 02540 Phone: 508-540-9771 Fax: 508-540-3158 | |
Mr. Garry L Brake, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 210 Jones Rd, Suite 2 5, Falmouth, MA 02540 Phone: 508-540-9771 Fax: 508-540-3158 | |
James B Knox, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 90 Ter Heun Drive, Suite 300, Falmouth, MA 02540 Phone: 508-540-0604 Fax: 508-457-0129 | |
Kenneth A Heisler, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 78 Main Street, Falmouth, MA 02540 Phone: 508-548-8317 Fax: 508-548-7407 | |
Mr. Alan Edwin Cordts, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 78 Main Street, Falmouth, MA 02540 Phone: 508-367-3937 Fax: 508-548-7407 | |
Terence Jean Christle, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 15 Garrison Rd, Falmouth, MA 02540 Phone: 508-540-0961 |